260 related articles for article (PubMed ID: 29288943)
1. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
2. Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors.
Qiu J; Chen W; Zhang Y; Zhou Q; Chen J; Yang L; Gao J; Gu X; Tang D
Eur J Med Chem; 2019 Aug; 176():41-49. PubMed ID: 31091479
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.
Gu X; Zhang Y; Zou Y; Li X; Guan M; Zhou Q; Qiu J
Bioorg Med Chem; 2021 Jan; 29():115892. PubMed ID: 33285406
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors.
Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X
Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
8. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X
Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q
Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
14. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
16. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication.
Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X
Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826
[TBL] [Abstract][Full Text] [Related]
17. 2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors.
Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X
Bioorg Med Chem; 2018 May; 26(8):1573-1578. PubMed ID: 29459146
[TBL] [Abstract][Full Text] [Related]
18. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.
Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH
Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
